Get started
LIAONING CHENGDALL

LIAONING CHENGDA

10.74CNYD
+0.03+0.28%
As of today at 03:30 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

600739 fundamentals

Key facts

Market capitalization‪16.38 B‬CNY
Dividend yield (indicated)0.93%
Price to earnings Ratio (TTM)47.08
Basic EPS (TTM)0.23CNY
Founded1991
Employees (FY)‪3.36 K‬
CEO—
Websitechengda.com.cn
About

Liaoning Cheng Da Co., Ltd. engages in the commodities distribution, import and export trading as well as biological drug manufacturing. It also engages in the trade of textile products, bulk steel raw materials, vaccines, development of energy and management of pharmacy retail stores. It provides agricultural production materials, financial and investment services. The company was founded on March 18, 1991 and is headquartered in Dalian, China.

Ownership
‪‪1.52 B‬‬
Free Float shares
‪‪872.50 M‬‬ (57.31%)
Closely held shares
‪‪649.82 M‬‬ (42.69%)
Free Float shares
‪‪872.50 M‬‬ (57.31%)
Closely held shares
‪‪649.82 M‬‬ (42.69%)
Capital structure
Market cap
‪‪16.38 B‬‬
Debt
‪‪12.70 B‬‬
Minority interest
‪‪2.60 B‬‬
Cash & equivalents
‪‪7.71 B‬‬
Enterprise value
‪‪23.97 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪16.38 B‬‬
Price to earning ratio (P/E)
47.08x
Price to sales ratio (P/S)
1.45x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
47.08x
Price to sales ratio (P/S)
1.45x
Valuation ratios
‪0.00‬
‪0.50‬
‪1.00‬
‪1.50‬
‪2.00‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪250.00‬
‪500.00‬
‪750.00‬
‪‪1.00 K‬‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−14%‬
‪−7%‬
‪0%‬
‪7%‬
‪14%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−1.10 B‬‬
‪0.00‬
‪‪1.10 B‬‬
‪‪2.20 B‬‬
‪‪3.30 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−1.00 B‬‬
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Import and Export Trade
Biopharmaceutical
Energy Development
Other Business
Share Capital
By country
Period: 2023
China
Asia
Americas
Africa
Europe
Oceania

Dividends

Dividend yield, history and sustainability

Dividend summary
43.96%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.93%
Last payment
0.10
Last ex-date
Aug 9, 2024
Dividend history
‪0.65%‬
‪0.80%‬
‪0.95%‬
‪1.10%‬
‪1.25%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.06‬
‪0.12‬
‪0.18‬
‪0.24‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−5.00 B‬‬
‪0.00‬
‪‪5.00 B‬‬
‪‪10.00 B‬‬
‪‪15.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪10.00 B‬‬
‪‪20.00 B‬‬
‪‪30.00 B‬‬
‪‪40.00 B‬‬
Assets
Liabilities